Roboz, G. J., Döhner, H., Pocock, C., Dombret, H., Ravandi, F., Jang, J. H., Selleslag, D., Mayer, J., Martens, U. M., Liesveld, J., Bernal, T., Wang, M. C., Yu, P., Shi, L., Guo, S., La Torre, I., Skikne, B., Dong, Q., Braverman, J., Nehme, S. A., Beach, C. and Wei, A. H. (2021) “Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial”, Haematologica. Pavia, Italy, 106(12), pp. 3240-3244. doi: 10.3324/haematol.2021.279174.